Search All News
Diana Martinez discusses the interaction between cannabis and psychiatric disorders.
"[Buprenorphine] is a tremendously powerful medication, saves many lives and prevents overdose, but there is a risk of misuse and diversion, albeit pretty low," says Dr. Francis Levin.
- August 31, 2018
New work from researchers at Columbia University Vagelos College of Physicians and Surgeons sheds light on how dopamine receptors signal within cells.
- August 1, 2018
A clinical trial conducted by Columbia University and Duke University suggest that donepezil may not improve cognitive performance in people at risk for Alzheimer’s disease who also had depression.
- May 23, 2018
Dr. Ilana Nossel is the medical director and co-associate director of OnTrackNY and an assistant professor of clinical psychiatry at Columbia University Irving Medical Center (CUIMC).
- May 3, 2018
Cognitive remediation can feasibly be implemented in large systems of care, according to researchers at the New York State Psychiatric Institute and Columbia University Irving Medical Center.
- April 30, 2018
A new study suggests that when a specific approach to supported employment (Individual Placement and Support) is implemented well it is associated with higher employment rates sustained over time.
Source:Washington PostApril 6, 2018
Initially, Seroquel seemed to have few side effects or complications. “The risks are far greater than I think has been represented,” said Dr. Mark Olfson.
- March 8, 2018
The ‘Man O’ War’ program, a research project studying the effectiveness of horse therapy for veterans with PTSD, will be now fully managed by Columbia University Irving Medical Center.
- December 14, 2017
Ketamine was significantly more effective than a commonly used sedative in reducing suicidal thoughts in depressed patients, according to researchers at Columbia University Medical Center (CUMC).